INTRODUCTION
The mitotic checkpoint, also known as the spindle assembly checkpoint (SAC), arrests cells before anaphase when conditions for successful chromosome segregation are not met [1] . Activation of the SAC leads to inhibition of the anaphase promoting complex or cyclosome (APC/C), an E3 ubiquitin ligase whose activity is essential for entry into anaphase. APC/C is active when bound to its coactivator Cdc20. Its inhibition takes place via a series of association/dissociation reactions that result in the sequestration of Cdc20 into a core complex, which also includes the checkpoint components Mad2, Bub3, and Mad3 (the ''mitotic checkpoint complex core'' or MCC core) [2] . The MCC core can bind APC/C, and recently it has been shown that MCC bound to APC includes in fact 2 molecules of Cdc20 [2] [3] [4] : one taking part in the MCC core and the second required for activating APC/C, as mentioned above. APC/C bound to MCC is unable to ubiquitinate its substrates, among them Clb2-the most important mitotic cyclin in budding yeast-and securin-an inhibitor of sister chromatids separation. This prevents their degradation by the proteasome and progression into anaphase.
Most of the essential checkpoint components (e.g., Mad1, Mad2, Bub3, Mad3/BubR1) are stable, and their concentrations have been reported to be constant throughout a cell cycle. By contrast, Cdc20, the target of the SAC, is actively transcribed and translated during an arrest [5] [6] [7] , when it accumulates in the nucleus. As Cdc20 production increases during an arrest, so does Cdc20 degradation, which is believed to require the binding of Cdc20 (primarily in the MCC) to APC/C [7, 8] .
Cells treated with agents that impair spindle assembly, such as nocodazole, can maintain an arrest for several hours before undergoing the metaphase-to-anaphase transition and leaving mitosis-an event known as adaptation [9] . Whether cells adapt with an active checkpoint is controversial. Originally, the process was described in mammals as ''slippage,'' since cells enter anaphase slipping through an active checkpoint [10] . In molecular terms, it was proposed that mitotic cyclins were slowly degraded despite APC/C inhibition, eventually reaching insufficient levels to sustain mitosis [10] . Mad2 localization at the kinetochores, however, may require Cdk1 activity [11, 12] , supporting an alternative scenario: the slow degradation of mitotic cyclins switches off the checkpoint, which in turn allows full APC/C activation and exit from mitosis. Obviously, these are two mutually exclusive options: in one case, adaptation takes place in the presence of an active checkpoint; in the second, it requires checkpoint silencing. A clear-cut analysis to assess the state of the SAC at the time of APC/C activation during adaptation has not been performed yet in any experimental system.
Understanding adaptation also requires addressing the observed large variability in adaptation times. In yeast, the earliest adapters enter anaphase after an arrest that lasts only 40 min, while the mitotic arrest in later adapters can span up to 600 min [13] . Given that yeast cells complete a cycle in 100 min, the time difference between early and late adapters is quite remarkable. As of today, we know very little about the source of variability in adaptation times: it may reflect simple stochastic processes or be explained with the presence of different subpopulations of cells, characterized by different propensities to adapt.
Here, we address the role of SAC inactivation in adaptation. Single-cell experiments provide the foundation for understanding the interplay between adaptation and mitotic checkpoint activity. We propose a mathematical model of the mitotic checkpoint that reproduces the dynamics of yeast cells under constant nocodazole treatment.
RESULTS

Clb2 Degradation Occurs in the Presence of Localized Mad2
To assess whether yeast cells transit into anaphase with an operational checkpoint, we imaged in real time and in the same cells Clb2-a target of APC/C Cdc20 -and Mad2-an essential component of the mitotic checkpoint. Tagging with mCherry did not alter the cell dynamics of Clb2 (Figures S1A and S1B). Mad2-GFP has been established previously [13] . We arrested cells in G1 by a factor, released them into nocodazole, and followed cells growing in microfluidic chambers with a fluorescence microscope. Degradation of Clb2 was used as an indicator of APC/C Cdc20 activation and transition into anaphase, while Mad2 localization provided a readout of mitotic checkpoint signaling. We monitored Mad2 localization with a ''Mad2 localization index'' (see STAR Methods, Image Analysis, Nocodazole), which was obtained by measuring the maximum intensity value of images filtered with a Laplacian of Gaussian. The Laplacian of Gaussian filter smooths out the noise and enhances isolated bright spots ( Figure S1C ). We confirmed that Mad2-GFP localizes with the checkpoint protein Bub3 during a metaphase arrest ( Figure S1D ).
To identify cells where Mad2 is localized, we set a threshold higher than Mad2 localization observed in G1-arrested cells, where Mad2 is not localized. We then plotted Mad2 localization at the time of Clb2 degradation for all cells and observed that in the large majority of cases (83%) Mad2 was still localized when Clb2 degradation started (a representative cell is shown in Figures 1A and 1B; Movie S1). In a much smaller fraction of cells (13%), Mad2 delocalized before Clb2 degradation started (for an example, see Figures S1E and S1F; the summary of observations is in Table S1 ). These cells were primarily late adapters (Figure 1C) (median of arrest = 375 min as opposed to 120 min for cells adapting with Mad2 localized). We speculate that in these cells the effect of nocodazole may have faded before they had a chance to adapt, although we cannot exclude that they adapt with an alternative mechanism. Finally, in 4% of cells we could not properly identify Clb2 degradation. The identification of cells adapting with localized Mad2 was robust to our choice of the localization threshold ( Figure S1G ).
Our further analyses were performed on cells adapting in the presence of Mad2 localization, as they represented the large majority of our observations. We plotted the distribution of Clb2 levels and Mad2 localization for different time points before and after Clb2 degradation ( Figure 1D ). Neither Clb2 nor Mad2 localization changed during 10 min preceding Clb2 degradation. However, the levels of Clb2 were largely diminished already 20 min after the start of its degradation, which was complete within 40 min. Mad2 delocalization followed similar dynamics, but it was delayed compared to Clb2 degradation and less and Clb2 (purple) at the indicated time points before and after Clb2 degradation (t = 0). In G1, we show only Mad2 localization. For each cell, Clb2 is normalized on its value when degradation starts. Only cells where Clb2 degradation starts with Mad2 localized are included. N: 3; n: 272. The edges of the boxes are the 25th and 75th percentile; inside the boxes we show the median. The whiskers extend to the most extreme data point within 1.5 times the length of the box. Dots are data points outside the whiskers. See also Figure S1 and Table S1. homogeneous, with some cells still having Mad2 localized well after Clb2 degradation.
Thus, our data show that in the large majority of cells resumption of the cell cycle takes place in the presence of localized Mad2. Clb2 degradation is followed by a slower and incomplete Mad2 delocalization. These observations are consistent with a slippage model in which cells leave mitosis despite an active checkpoint.
A Model of the Mitotic Checkpoint to Explain Adaptation Dynamics
To analyze the phenomenon of adaptation, we plotted the cumulative distribution of adaptation times, measured from Clb2 accumulation to Clb2 degradation (mitotic arrest shown in Figure 1A ). The distribution shows a delay of roughly 40 min, followed by what looks like a saturating exponential function (Figure 2A) . Such a distribution would be expected if adaptation were an entirely random event, analogous to the radioactive decay of an atom.
We asked whether the cumulative distribution could be explained if steady-state APC/C Cdc20 levels were kept below a critical ''anaphase threshold'' by an operational SAC, but that random fluctuations around the mean could overshoot the threshold and drive cells into anaphase. To investigate this idea, we constructed a simple mathematical model of the SAC network and tested whether it can reproduce the observed distribution of adaptation times.
The presence of an anaphase threshold is consistent with the concept that a positive feedback loop controls entry into anaphase. This result was first suggested on the basis of a mutual antagonism between the SAC and APC/C [14] and is in agreement with more recent data that show a similar doublenegative relationship between APC/C Cdc20 and PP2A Cdc55 [13, 15] , and between Cdk1 activity and the SAC [11] . Here, for Lower panel: cells of the indicated genotypes (strains yAC3430, yAC3307, yAC3367, yAC3365, yAC3436, yAC3353, yAC3261, yAC3427, yAC3262, yAC3371) were arrested in G1 with a factor and released in nocodazole. After 110 min, samples were taken for protein extract preparation and immunoblotted with anti-myc antibodies. N: 2. (F) Simulated cumulative function of adaptation times produced by the model in (B), reactions in Table S2 , parameters in Table S3 . In the inset, two representative trajectories of individual cells that cross the anaphase threshold at two different times are indicated by the solid dots. The same dots are displayed in the cumulative curve (solid line), which is fitted with an exponential (dotted line) after a delay. See also Figure S2 and Tables S2 and S3. the sake of simplicity, we just assumed the presence of a threshold for APC/C Cdc20 to trigger entry into anaphase.
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However, we included realistic molecular details concerning the mitotic checkpoint network, based on the following core data (see Figure 2B ; Data S1; STAR Methods, Mathematical Model; Table S2 ): (1) the only molecular species being synthesized and degraded is Cdc20 [5] [6] [7] ; (2) degradation takes place primarily from the inhibited form of APC/C, in cis [8, 16] ; (3) when the SAC is not active, Cdc20 binds and activates APC/C [2] ; (4) when the checkpoint is engaged, it drives the formation of MCC, which can bind and inhibit the active APC/C Cdc20 giving rise to the inhibited species APC/C inhib [3] .
The mechanism of MCC release from APC/C requires further investigation. In the model, we assume that APC/C inhib can be disassembled by degradation of one molecule of Cdc20 and release of free APC/C, Mad2, Mad3, and the second Cdc20 molecule. However, we obtained similar results when assuming that APC/C Cdc20 is a product of Cdc20 degradation from APC/C inhib (To APC/C CDc20 in Figures S2A and S2B ). [7] ), concentrations of Mad2, Mad3, and Cdc23 (an essential subunit of APC/C) ( Figure 2D ), and relative amounts of Cdc23 and Cdc20 ( Figure 2E ). The dissociation constants for APC/C Cdc20 and APC/C MCC were estimated indirectly from published data (see STAR Methods, Mathematical Model; Table S3 for a thorough explanation of the choice of parameters). The model's behavior was robust to changes in parameters estimated indirectly ( Figure S2D ).
Stochastic Simulations Reproduce Cumulative Distributions of Mitotic Arrest
We used the Gillespie algorithm to generate stochastic trajectories for the model, incorporating the propensity of each chemical reaction. This description assumes that noise is mainly due to the randomness of molecular reactions in the network. Since the molecular species involved are present in low levels (Table S3 ), the amount of noise is considerable. We started each simulation from an initial state with Cdc20 = 0, corresponding to entry into mitosis. As a result of Cdc20 synthesis, APC/C Cdc20 levels initially increase, and after a short transient they fluctuate around a steady state. Due to the noise, different trajectories (i.e., different cells) cross the anaphase threshold at different times (inset in Figure 2F ). In first approximation, at steady state the probability to hit the threshold is independent of time: even though on short timescales the state of the system is dependent on previous time points, the system quickly loses its memory. This is apparent in a decrease of the autocorrelation of stationary APC/C Cdc20 levels, which drops exponentially to values around zero in $5 min ( Figure S2E ), a timescale significantly shorter than the typical adaptation time. The expected cumulative distribution of waiting times for a random event, whose probability is the same at any point in time, is exponential.
More formally, the stationary APC Cdc20 trajectory from our model is in relevant respects similar to an Ornstein-Uhlenbeck process for which it has been shown that the distribution of first passage times across a threshold is exponential, provided that the threshold is sufficiently far from the mean compared to typical fluctuations [15] . Accordingly, our simulations produce cumulative distribution functions for adaptation times that are in agreement with our experimental data (Figures 2A and 2F) . The fact that the cumulative distribution of adaptation times is exponential suggests that all cells share the same time-independent propensity to adapt. A systematic comparison with alternative models describing subpopulations with different rates supports this conclusion for our experimental data ( Figure S2F ; STAR Methods, One versus Two Subpopulations).
Similarly to what we observed experimentally, the model has an initial delay due to the transient to reach the stationary state. This delay, however, is shorter than in the experiments, where no cells adapt during 40 min after Clb2 accumulation. This discrepancy can be explained by noticing that in the model the arrest is measured from the start of Cdc20 accumulation. In the experiment, by contrast, we take Clb2 production as the starting point, which precedes APC/C Cdc20 formation, Clb2 being required for Cdc20 production [5] and APC/C-Cdc20 binding [17] . In summary, our stochastic model reproduces both the distribution of adaptation times and the observed delay by simulating the known protein network with an anaphase onset that is caused by the random crossing of an APC/C Cdc20 threshold.
The SAC Network Is Resistant to High Cdc20 Levels In the model, the probability of adaptation depends crucially on the distance between the steady state of APC/C Cdc20 and the anaphase threshold. To investigate this dependency, we perturbed the levels of APC/C Cdc20 by modulating both in the model and experimentally the synthesis of Cdc20, the target of the checkpoint. According to the deterministic version of our model, which reproduces the average behavior of individual stochastic trajectories [18] , the steady-state levels of APC/C Cdc20 and APC/C inhib increase with Cdc20 production rate. This is true as long as APC/C and Mad2/Mad3 are in excess, which is the case in wild-types. The scenario changes when Cdc20 is so high that APC/C and Mad2 or Mad3 become limiting: at this point, the steady-state levels of APC/C Cdc20 , MCC, and APC/C inhib become insensitive to further changes in Cdc20 production rate. By reducing Cdc20 below wild-type levels, instead, cells are expected to adapt less frequently, since in this setting Cdc20 becomes limiting and the steady state for APC/C Cdc20 decreases and moves further away from the threshold (Figure 3A) . Accordingly, numerical simulations of the model show an increase in adaptation rates when increasing Cdc20 expression, an effect that eventually levels off ( Figure 3B ).
To test these predictions, we first modulated the number of CDC20 genes under the endogenous promoter (i.e., CDC20pr). We inserted 2, 3, and 5 copies of CDC20 (STAR Methods, Quantification of extra CDC20; Figure S3A ) in cells expressing Clb2-mCherry and Mad2-GFP. The amount of protein accumulated during a metaphase arrest scales with the number of genes (Figure S3B) , and accordingly the activity (defined in Figure S3C ) of one individual CDC20pr is not lowered by the presence of additional copies of CDC20pr ( Figure S3D ). We did not follow Cdc20 in single cells since, similarly to the G1 cyclin Cln2 [19] , high turnover of Cdc20 relative to the maturation times of fluorescent proteins prevents direct visualization of Cdc20 in living cells. Fast maturing fluorescent proteins such as super folder green fluorescent protein (sfGFP) are partially resistant to proteasomal degradation and hence lead to high background signal [20] . Indeed, we noticed that Cdc20-sfGFP was over-stabilized, leading to accumulation of unspecific fluorescent signal.
Strains supernumerary for CDC20 are slightly more sensitive than wild-type cells to microtubule depolymerizing drugs (e.g., benomyl), but much less sensitive than SAC-deficient mad2D cells ( Figure S4A ). Cells lacking MAD3 are also checkpoint deficient, cannot form MCC, and do not arrest under treatment with microtubule depolymerizers. mad3D cells, indeed, show a much faster rebudding kinetics in nocodazole compared to CDC20 5X ( Figure S4B ). Collectively, these data indicate that the checkpoint as such is still functional in strains carrying extra CDC20.
As in Figure 2A , we then treated cells with nocodazole and measured the cumulative distributions of adaptation times in cells supernumerary for CDC20. Cells adapted faster as the copy number increased: the major reduction in adaptation times took place going from one to two copies, whereas further increasing copy number had less effect ( Figure 3C) . Similarly to what we observed in the wild-type, most cells started to degrade Clb2 in the presence of localized Mad2 ( Figure S4C ). The opposite effect was observed when we decreased the expression of Cdc20 by using diploid cells heterozygous for CDC20 (see STAR Methods, Image Analysis, Diploids). In agreement with what observed in haploids, diploids CDC20 3X and 5X had similar dynamics, faster than wild-type cells. Heterozygous CDC20/cdc20 diploids instead showed a propensity to adapt which was $60% that of wild-types CDC20/CDC20 ( Figure 3D ; Table S4 ). When we compared simulated and experimental mean adaptation times for the different strains, we found that the global qualitative behavior of our model well recapitulates the dependency of adaptation kinetics with altered Cdc20 expression rates ( Figure 3E) . showed that the heterozygous CDC20/cdc20 has 60% of propensity to adapt of wild-type cells, Table S4 . We used a different symbol (square) and a dotted line to emphasize the fact that this result was obtained in a different experimental system. See also Figures S3 and S4 and Table S4 .
In conclusion, our data show that, in agreement with the model, adaptation dynamics becomes faster but then appears to saturate as the expression rate of Cdc20 increases.
APC/C inhib and MCC Saturate with Two Copies of CDC20
Increasing Cdc20 expression did increase the chance of cells to adapt, but eventually the effect leveled off. According to the model, this is because interactors of Cdc20 (Mads and APC/C), which are present in similar concentrations compared to endogenously expressed Cdc20 (Figures 2D and 2E ), become limiting when Cdc20 is overexpressed. We thus tested experimentally whether the inhibited form of APC/C, which includes both Cdc23 and Mad3, saturates when we increase the dosage of Cdc20.
To quantify APC/C inhib in vivo, we used fluorescence cross correlation spectroscopy (FCCS), a technique that detects the formation of protein-protein complexes by analyzing the co-diffusion properties of fluorescently tagged proteins [21] (STAR Methods, Fluorescence Correlation Spectroscopy). We used the protein pair Cdc23-mCherry and Mad2-GFP as reporters for MCC binding to APC/C (for an example of correlation traces, see Figure S5A ). Cells were arrested in a factor and released into nocodazole. We analyzed all cells that were arrested in mitosis, as detected by the presence of large buds. As negative controls, we analyzed G1-arrested cells, cycling cells, and cells treated with nocodazole but lacking MAD3. As expected, in neither case we could see an increase of signal after nocodazole addition. Instead, when we analyzed the presence of Mad2/Cdc23 complexes in wild-type cells arrested in mitosis by nocodazole, we could detect a cross-correlation signal significantly higher than in the controls ( Figure S5B ; STAR Methods, Fluorescence Correlation Spectroscopy). Repeating the experiment with strains carrying extra CDC20, we observed that the signal increased with extra copies of CDC20, reaching saturation after 2 copies ( Figure 4A ). We observed that MCC, detected with Mad3-mCherry and Mad2-GFP, also saturates with two copies of CDC20 ( Figures  4B and S5C) .
Together, these results validate FCCS as a tool to measure inhibited APC/C in vivo and demonstrate that increased expression of Cdc20 leads to saturation of the interaction of MCC with APC/C.
A Pulse of Cdc20 Induces Fast Adaptation in Most, but Not All, Cells One key conclusion suggested by our model is that all cells have the same probability per unit of time to adapt. To test this point, we exposed cells to transient high levels of APC/C Cdc20 by overexpressing Cdc20 for a limited time. Also in this case, higher levels of Cdc20 are expected to increase the probability of entering anaphase, but, owing to the relatively short duration of the stimulus, not all cells will respond. After silencing the exogenous source, Cdc20 will quickly return to endogenous levels (Cdc20 half-life is approximately 7.5 min, Figures 2C and S2C and [7] ). According to our model, cells that do not adapt under the transient stimulus ought to have the same probability of adapting as cells that were never exposed to high levels of Cdc20. That is, the pulse is not expected to select cells more prone to adapt, but to cluster randomly two groups of otherwise identical cells.
To prove this point experimentally, we placed CDC20 under the control of the MET3 promoter, which can be activated transiently by removal of methionine from the growth medium [19] . Since nocodazole is not active in the synthetic media [22] necessary for MET3 promoter regulation, we induced the checkpoint by overexpressing Mad2 from the GAL1 promoter [9] . It has been shown previously that Mad2 overexpression induces a bona fide SAC arrest [23] . This setting can be represented by our model ''With Mad3'' in Figure S2A , with the proper choice of parameter values ( Figure S6A ). We monitored nuclear division, which occurs normally in cells that adapt in high levels of Mad2 in budding yeast, as a proxy for transition to anaphase. Nuclei were made visible by tagging histone 2B with mCherry.
As explained above, we could not follow Cdc20 directly. To circumvent this problem, we monitored MET3 promoter activity regulating Cdc20 expression (defined in Figure S3C ) using a coupled MET3-VENUSdegron construct [24] . We confirmed that the activities of the two MET3 promoters are well coupled ( Figure S6B and [19] ).
Cells were released from a G1 arrest, and, after 110 min, when arrested in metaphase (i.e., large budded), methionine was removed for 35 min (Early pulse in Figure 5A , experimental details in Figure S6C ). Microfluidic devices allowed for media switching and long time recording with a fluorescence 6 .71e-01, 2.88e-01. The edges of the boxes are the 25th and 75th percentile; inside the boxes we show the median. The whiskers extend to the most extreme data point within 1.5 times the length of the box. Dots are data points outside the whiskers. See also Figure S5 .
microscope. The exogenous Cdc20 expression was more than 3 times stronger than from the endogenous promoter ( Figure S6D ). In response to the pulse, cells showed two different behaviors: some adapted very quickly (in red), while the remaining cells (in blue) showed adaptation dynamics similar to cells kept all the time in methionine (no pulse in Figure 5A ; a direct comparison in Figure 5B ). The latter showed adaptation dynamics similar to wild-type cells not carrying the MET3-CDC20 construct, such that Cdc20 is only expressed from the endogenous promoter (data not shown).
Interestingly, the presence of slow and fast exit events cannot be explained by differences in MET3pr activities, which are very similar in all cells ( Figure 5C ). This result points to a lack of a direct correlation between the extent of Cdc20 overexpression and APC/C Cdc20 levels and can be explained as an effect of the saturation of APC/C Cdc20 ( Figure 3A ).
The effect of the pulse was independent of the time of MET3pr activation. When the pulse was given 1 hr later (Late pulse in Figure 5A) , the cell population separated again into a quickly adapting group (in red) and a group (in blue) adapting with the wild-type-like dynamics of cells that do not experience the pulse ( Figure 5B ). The distributions of quickly adapting cells under the early or late pulse were not different (STAR Methods, Image Analysis, Pulse).
Cells that do not adapt immediately after the pulse follow the same adaptation dynamics as cells that are kept in methionine at all times. Thus, we also expect that cells that have not adapted to the pulse can respond to a second pulse. They should do so with the same dynamics of cells that adapt during the first pulse, since they will be exposed to the same level of APC/C Cdc20 .
To test this prediction, we treated cells with two consecutive pulses of Cdc20 ( Figure 5A , double pulse). The first pulse, elicited the same effect described above (in red in Figure 5A ). The fraction of cells that had not adapted after the early pulse adapted in response to the second pulse (green histograms in the double pulse of Figure 5A ). The early pulse did not seem to leave any lasting effect on these cells, since the distribution of adaptation times was indistinguishable from cells that had adapted after only one late pulse (red histograms in the late pulse versus green histograms in the double pulse in Figure 5A ; see also STAR Methods, Image Analysis, Pulse).
In summary, our results confirm that, in a mitotically arrested cell population, cells have the same propensity to adapt when exposed to extra levels of Cdc20; the probability of adapting in response to a Cdc20 overexpression pulse appears to be time invariant and insensitive to previous overexpression pulses.
DISCUSSION
Our data demonstrate that cells adapt to an operational SAC. One key event of adaptation, Clb2 degradation, takes place when Mad2 is still well localized, and likely signaling. In many cells, but not all, Mad2 delocalized from kinetochores after Clb2 degradation. Thus, our results do not exclude that adaptation is further accelerated in some cells by the weakening of the checkpoint fostered by adaptation itself. However, our data show that cells do not need to switch off the checkpoint signal to adapt, in agreement with the original observation from Brito and Rieder [10] .
This result sets the stage for a model of adaptation in which APC/C Cdc20 is able to drive cells through anaphase regardless of the active formation of the inhibitor MCC core. We implemented this concept by developing a stochastic model where APC/C Cdc20 levels fluctuate around a steady-state value below an anaphase threshold. Fluctuations are primarily due to the small number of molecules of APC/C, Cdc20, and Mads. Rarely and by chance, APC/C Cdc20 levels can hit the threshold and drive cells through adaptation. Despite its simplicity, the model reproduces the dynamics of adaptation of the majority of wild-type and Cdc20-overexpressing cells. MET3pr-CDC20 MET3pr-Venus GAL1-MAD2 HTB2-mCherry cells (yAC2341) were grown and synchronized in complete low fluorescent synthetic medium with raffinose (SCR) and released from an a factor arrest in the same medium supplied with 2% galactose, to activate the GAL1 promoter. During the experiment, cells were grown in microfluidic devices. The MET3 promoters were activated by removal of methionine (we call it ''pulse,'' shown as gray-shaded rectangles in A), which occurred either early or late, the time difference being 1 hr. For a schematic of the experiment, see Figure S6C . 
Assumptions and Pitfalls of the Model
In our model, a mitotic arrest is described as a steady state. However, during an arrest cell growth continues, which may give rise to slow timescale dynamics that make adaptation more likely in the long run, e.g., the anaphase threshold may decrease in time, or the average levels of APC/C Cdc20 may increase in time. Yet, we believe that the steady-state approximation is largely valid. First, our data are well reproduced by an exponential distribution where the propensity to adapt does not change over time. Second, the transient increase of Cdc20 levels elicits the same response whether it is given 1 hr earlier or later during a mitotic arrest.
Although satisfying, the model has two shortcomings. First, there is a smaller fraction of cells (13%) where the SAC is silenced before Clb2 degradation. We hypothesize that in these cells nocodazole fades off, but we cannot exclude that they manage to escape via a different mechanism. However, given their small number, introducing this fraction of cells in our analysis does not substantially change our results. Second, the agreement between model and data for the overexpression experiments is only qualitative, since in reality Cdc20 overexpression has a smaller effect than what is predicted by the model ( Figure 3E ). We believe that the reason for this discrepancy lies with the still poorly understood processes that regulate Cdc20 production and degradation during a mitotic arrest.
With Two Cdc20 in APC/C inhib , You Can't Flip the Balance It is worth noticing that one single molecular species at steady state would have sufficed to reproduce an exponential distribution of adaptation times. However, the predicted ability to buffer extra Cdc20 levels required all key molecular players we introduced in the model. In particular, this result is the necessary consequence of having two molecules of Cdc20 in APC/C inhib , Figure 2B . Since the active form APC/C Cdc20 and the inhibitor MCC are the substrates of the inhibited form APC/C inhib , newly synthesized Cdc20 goes both to the activator (APC/C Cdc20 ) and to the inhibitor (MCC), which in turn binds to form the inactive APC/C inhib . The net effect is that extra Cdc20 can never flip the balance toward the active form but can at most achieve a ''frozen state'' in which there is no free APC/C and no free Mads/Bubs, and the levels of APC/C Cdc20 and APC/C inhib are insensitive to further increases of Cdc20 expression.
Checkpoint Deficiency or Anticipated Adaptation?
Our model offers a framework to distinguish between two ways cells can produce enough APC/C Cdc20 to enter anaphase. The first mechanism is described in this manuscript: average APC/C Cdc20 levels across the population are kept below the anaphase threshold, and individual cells can adapt via random fluctuations. An alternative scenario is that the average APC/C Cdc20 levels of the whole population are sufficient to cross the threshold and drive all cells into anaphase. In this case, the transition is not due to random fluctuations but rather to the deterministic dynamics of APC/C Cdc20 . This happens in SAC-deficient cells, e.g., cells with deleted MAD3, as in Figure S4B . The two processes are radically different ( Figure 6 ). Adaptation is characterized by a large cell-tocell variability and is slower. SAC-deficient cells, by contrast, cross the threshold much faster, and more coherently.
The distinction between deficiency and adaptation is very relevant for interpreting conditions that impair the ability of cells to respond to SAC-inducing stimuli. Cells overexpressing Cdc20 in our view anticipate adaptation but are SAC proficient. Deletions of SAC components, or mutants of Cdc20 that do not take part in MCC, are instead SAC deficient. Along this line, we can reconcile previous results of Cdc20 overexpression with our own. Based on Pds1 stability under nocodazole treatment, it was reported that budding yeast cells expressing multiple copies of myc-tagged Cdc20 behave halfway between wildtype and SAC-deficient cells [7] . For this reason, Cdc20-overexpressing cells were considered checkpoint deficient. Based on our results, we argue that these cells have an anticipated adaptation but are SAC proficient. Likewise, yeast cells overexpressing Cdc20 from a GAL1 promoter have been described as SAC deficient [25] . Yet, these cells take roughly 30 min to degrade 50% of Pds1 under a nocodazole arrest. This result is comparable with ours since even the anticipated adaptation of CDC20 5X cells shows a time lag of 40 min for 50% of cells to adapt. Thus, we suggest that the SAC is proficient in cells overexpressing Cdc20 from the GAL1 promoter, but adaptation is anticipated.
Although both in yeast and mammals the SAC is active during adaptation, in mammalian cells Cyclin B is slowly degraded throughout the arrest. Adaptation time is extremely variable also in mammals (also modeled as a stochastic process [26]), and the kinetics of Cyclin B degradation is not constant in time and quite different in different cells. How the random fluctuations of APC/C Cdc20 may contribute to this variability in higher eukaryotes is currently not known. Extending our model to adaptation in mammals is an important future goal.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Andrea Ciliberto (andrea.ciliberto@ifom.eu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Yeast strains and growth conditions All yeast strains (Table S5) were derivatives of or were backcrossed at least three times to W303 (ade2-1, trp1-1, can1-100,  leu2-3,112, his3-11,15, ura3 prepared using yeast nitrogen base lacking ammonium sulfate, added afterward. Synthetic medium was either complete or lacking methionine, supplemented with 2% raffinose (SCR, SCR-met) or 2% raffinose and 2% galactose (SCRG, SCRG-met). For FCS experiments, cells were grown in synthetic complete medium, prepared using yeast nitrogen base lacking folic acid and riboflavin, and 1% Bacto Peptone. Unless otherwise stated, a-factor and nocodazole were used at 3 mg/ml and 15 mg/ml respectively and synchronization experiments and movies were carried out at 30 C. To induce the GAL1 promoter, galactose was added to 2% concentration 1hr before a-factor release. To repress the MET3 promoter, methionine was added at 2mM or 2,6mM. Cycloheximide was added at 1mg/ml. Benomyl concentration in plates was 12,5 mg/ml and DMSO was at 1%.
METHOD DETAILS
Plasmid constructions and genetic manipulations Plasmids are listed in Table S6 .
Plasmid pAC130 carrying MET3-CDC20 construct was synthetized by Epoch Life Science and contains À600bp of MET3 promoter and CDC20 ORF from ATG to +392bp. MET3-CDC20 from pl130 was cloned in YipLac211 (KpnI/PstI) and integrated at URA3 locus by digestion with NcoI. Single integration was checked by Southern blot analysis.
MET3 promoter from plasmid pAC130 was cloned in in PacI/NotI sites of plasmid pGC25 (a gift from Fred Cross, Center for Studies in Physics and Biology, The Rockefeller University, New York, NY 10065, USA; from [33] ) to obtain MET3-yEVenus (plasmid pAC136). pAC136 integration was directed at TRP1 locus by XbaI digestion. Single integration was checked by Southern blot analysis.
CDC20 sequence from À411 to +391 was amplified by overlap extension PCR on the plasmid used for Cdc20 tagging in [25] and on pAC130 and cloned in YipLac204 to obtain plasmid pAC138. pAC138 was digested with KpnI and CDC20 sequence was cloned in YipLac211 to obtain plasmid pAC142. pAC138 and pAC142 integrations at TRP1 and URA3 loci were obtained by digestion with EcoRV and copy number was evaluated by Southern blot (for integration at TRP1) or qPCR (for integration at URA3 or TRP1), see Figure S3A and below, ''Quantification of extra CDC20''. To test for CDC20 functionality, in the strains carrying additional copies of CDC20 both the endogenous CDC20 and CDH1 were removed and viability was verified.
MET3-mCherry was synthetized by Genscript and cloned in BamHI/EcoRI of Yiplac211 to give plasmid pAC156. It contains 600bp of MET3 promoter and 392 bp of CDC20 terminator (as in pl130). mCherry sequence has a silent mutation to remove internal NcoI site. pAC156 was inserted at URA3 site by NcoI digestion. Single integration was checked by Southern Blot.
To obtain plasmid pAC97, CLN2 promoter from CLN2pr-Venus-degron (a gift from Fred Cross, Centre for Studies in Physics and Biology, The Rockefeller University, New York, USA, see [19, 34] ) was swapped with CDC20pr (412bp) obtained from the plasmid used for Cdc20 tagging in [25] . CDC20pr-Venus-degron from pAC97 was cloned by PCR duplication at CDC20 locus [35] .
CLB2-3mCherry was tagged immediately before the STOP codon by one-step tagging [36] by PCR amplification from plasmid pST70 [21] .
MAD3 and MND2 chromosomal deletions were generated by one-step gene replacement [37] . To reduce autofluorescence, in all the strains used for FCS, the mutated ade2-1 gene was replaced by one-step gene replacement with wild-type ADE2 gene amplified by PCR from plasmid pRS402 [38] . In the strains used for FCS, plasmids pST70 and pST72 [21] were used for one-step tagging [39] of MAD2, MAD3, BUB3 and CDC23 genes. The strains obtained were then successfully tested for viability at different temperatures (23 , 30 , 37 ) and with Ethanol/Glycerol as carbon source to check mitochondrial functionality. Those in which Mad2, Mad3 or Bub3 have been tagged were successfully tested for SAC proficiency.
Mad2-3GFP fusion used in all except FCS experiments was a gift by Tomo Tanaka (Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Scotland, UK). bub3D, 18MYC-PDS1::LEU2 and his3-11,15::HIS3tetR-GFP, ura3::3XURA3tetO112 strains were a gift by Simonetta Piatti (Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM), CNRS, Montpellier, France). cdc20D and HTB2-mCherry were a gift from Fred Cross, Center for Studies in Physics and Biology, The Rockefeller University, New York, USA (strain 2147-1c). CDC23-Myc9, Myc9-CDC20, CDC27-Myc9, APC5-Myc9 and APC4-Myc9 strains were a gift by Wolfgang Zachariae (Laboratory of Chromosome Biology, Max Planck Institute of Biochemistry, Martinsried, Germany, YWZ149 and YWZ1010, respectively). mad3::TRP1 was a gift by Peter de Wulf (University of Trento, Centre for Integrative Biology, strain PDW747).
Homozygous diploid strains were obtained by crossing two haploids with the same genotype, by isolating zygotes and by checking the ploidy by FACS analysis of DNA content of cycling cultures. Deletion of CDC20 in strain 3804 was obtained by one-step gene replacement [37] of one of the two chromosomal copies of the gene, then checked by PCR.
Quantification of extra CDC20
Additional copies of CDC20 were placed at TRP1 or URA3 loci, under the endogenous promoter and terminator, from 411bp upstream ATG to 391bp downstream STOP codon. To estimate CDC20 copy number, we performed qPCR on genomic material. To quantify the number of insertions at TRP1 locus ( Figure S3A, left) , we used ACT1 as reference gene. We also included in the analysis strains carrying extra copies of CDC20 but deleted for the endogenous gene. qPCR output for yAC2398 (trp1::CDC20::TRP1, CDC20) was approximately twice as for the wild-type strain. For yAC2400 (trp1::CDC20::TRP1 (2X), CDC20) it was three times compared to wild-type. Accordingly, when we deleted endogenous CDC20 in yAC2398 we had the same signal as in the wildtype, while we had approximately twice as much with the same deletion in yAC2400. yAC2398 was then used as parental for CDC20 (2X) strains and yAC2400 for CDC20 (3X).
To measure gene copy number in the selected URA3 transformant yAC2675, we created a calibration curve using the haploid wildtype and two diploid strains with different CDC20/MND2 ratios ( Figure S3A, right) . We used MND2 as reference gene. The results suggest that haploid transformant yAC2675 (unknown number of CDC20 integrations at URA3) carries two additional copies of CDC20. Although we cannot be absolutely sure about this result, we notice that if it carried only one extra copy, or more than two, our results would not change substantially. Thus, we refer to strains that carry the additional CDC20 from this URA3 transformant and the two copies at TRP1 locus from yAC2400 as CDC20 (5X).
Protein extracts and western blot analysis
For western blot analysis, TCA protein extracts were prepared according to [40] and proteins were transferred on a nitrocellulose membrane. To evaluate Cdc20 degradation rate cells were fixed in cold NaN 3 1mg/ml. Primary antibodies were used as follows: Cdc20 at 1:500, Clb2 at 1:1,000, Cdc28 at 1:100 and Pgk1 at 1:5000. Secondary antibodies were used as follows: Cdc20, anti-goat at 1:5000; Clb2, anti-rabbit at 1:0000; Cdc28, anti-goat at 1:5000; Pgk1, anti-mouse 1:10000. Proteins were detected by an enhanced chemiluminescence system (Invitrogen) according to the manufacturer's instructions. Blots were acquired as digitalized images by a Chemidoc XRS+System (Bio-Rad Laboratories). Signal was quantified using ImageJ or Image Lab software.
Image acquisition
Single-cell analysis was performed growing cells at 30 in microfluidic chambers (CELLASIC). Time-lapse movies were recorded using a DeltaVision Elite imaging system (Applied Precision) based on an inverted microscope (IX71; Olympus) with a camera (CoolSNAP HQ2; Photometrics) and a UPlanFL N 60x (1.25 NA) oil immersion objective lens (Olympus). Mad2-GFP was acquired using 11 Z stacks spaced 0.3 mm (for haploids) or 0.38 mm (for diploids), at 10% lamp power for 0.07 s. Deconvolved images were computed using SoftWoRx software and projected using the maximum intensity projection. Clb2-Cherry was acquired with a single Z stack, 10% lamp power for 0.5 s. MET3pr-Venus, MET3pr-Venus degron and CDC20pr-Venus degron were acquired using a single Z stack, 10% lamp power, 0.05 s. Ht2b-Cherry was acquired with a single Z stack, 10% lamp power, 0.15 s. The coexistence of different Z stack settings was made possible by ad hoc scripting of the DeltaVision acquisition procedure. The phototoxicity of the acquisition setting was measured by comparing the cell cycle duration in excited and non-excited cells, for which we detected no significant difference.
GFP, Venus and Cherry were acquired using single bandpass filters (EX475/28 EM523/36 for GFP and Venus, EX575/25 EM632/60 for Cherry).
Image analysis
We did not perform an a-priori study to define the optimal sample size for single cell experiments. We have rather aimed at analyzing as many cells as possible, with the limitations that come with the microfluidic technology. We have found that experiments with more than 100 cells give reproducible results.
Cells were segmented using the software Phylocell (developed by Gilles Charvin and colleagues [24] and available on GitHub [27]). Pixels in the segmented areas of mother and daughter cells were analyzed together until cells divide. The mean value of the background, identified as the non-segmented area, was subtracted for each frame. Fluorescence traces were analyzed using custom software in MATLAB. Nocodazole (Figures 1, 2 , and 3) Mad2-GFP localization was determined using a Localization Index (LI) defined using the Laplacian of Gaussian operator whose matrix is À0.0085 0.0038 À0.0085 0.0038 0.0187 0.0038 À0.0085 0.0038 À0.0085
This operator smooths out the noise and enhances edges between dark and bright areas of the image [41] . The effect of the filtering can be appreciated in Figure S1C . We used the maximum of the filtered image as Localization Index.
To define a threshold above which Mad2 is considered to be localized, we observed that the Mad2 localization index drops rapidly from high to low values when cells adapt. This result can be appreciated by plotting the number of cells with a Mad2 localization index above a chosen value as a function of time (see Figure S1G ). The curves representing values from 7 to 10 are close to each other, especially in their descending dynamics around 200 min. This means that in the majority of cells the Mad2 localization index changes from indicating complete localization (> 10) to complete delocalization (< 7). This result gave us the freedom to choose any value within this interval. To be conservative, we chose the highest value: 10.
The Clb2-mCherry mean signal was smoothed using a Savitsky-Golay filtering. Its accumulation was used as readout of mitotic entry and identified as the maximum of the second derivative. The beginning of Clb2 degradation was identified as the time after the first budding where the smoothed Clb2 signal starts decreasing and falls.
We excluded from the analyses in Figures 2A and 3C cells where Mad2 is not localized when Clb2 degradation starts (i.e.: Mad2 localization index is below 10) (12% of cells across all strains). Cells where Mad2 delocalizes and Clb2 is stable (4%) also are not in the database (Table S1 ): we interpret them as cells where Clb2 signal is not properly detected.
SAC-deficient cells (mad3D) have a shorter mitosis, and thus Clb2 is degraded before mCherry can mature. For this reason, in the experiments of Figure S4B we cannot measure mitotic arrest as the time between Clb2 accumulation and degradation. Instead, we keep track of the time between the first and the second budding (i.e., between entry into S-phase after synchronization in G1 and after adaptation). Diploids ( Figure 3D ) Diploid cells could not be synchronized in G1. Given the short duration of G1, and the fact that we acquired one image every 10 min, we could not have a clear negative control for Mad2 localization index. This prevented us from selecting cells based on this signal, as we did for haploids in Figure 1 . Yet, we needed to exclude from the analysis of diploids those cells that were in mitosis at the time of nocodazole treatment or entered mitosis before they could experience the effect of the drug. To this aim, we used results from synchronized haploids (Figure 1) , where Clb2 levels increased roughly 50 min after nocodazole treatment. Thus, we included in the analysis of diploids only cells where Clb2 signal rises later than 50 min from nocodazole addition.
Unlike haploids, a sizeable fraction of diploid cells died in metaphase (13% overall, 25% in the heterozygous), for reasons that are currently unknown: we call them censored observations. The presence of such observations forced us to change the statistical model used to estimate the propensity of cells to adapt. We did not fit the cumulative distributions with an exponential as we did with haploid cells, since this procedure would have ignored censored cells. Instead, to include these cells, we used the Cox proportional hazard model. We summarized the results using the hazard ratio, normalized to the CDC20/CDC20 diploid in Table S4 . In Figure 3D we plotted the Kaplan-Meier estimate of the cumulative distribution function of the time spent in mitosis. Pulse ( Figure 5 ) To estimate Venus synthesis rate (i.e., activity) from the MET3pr or CDC20pr ( Figures S3D, 5C , S6B, and S6D), the time of promoter activation was identified by the maximum of the second derivative. The raw signal was smoothed using a moving window of size 4. From the moment of promoter activation for a minimum of 40 min the signal was fitted with a straight line. Promoter activity was identified as the slope of the fitted line, similarly to what proposed in [19] (see Figure S3C for details).
Both early and late pulses were given in mitotic cells (i.e., dumbell) before the onset of adaptation driven by the endogenous expression of Cdc20. Unlike cells adapting in nocodazole, these cells were grown in minimal medium, which likely explains their delayed adaptation onset.
To compare the distributions of early and late pulses (first two rows, red histograms in Figure 5A ), we performed a KolmogorovSmirnov test. The effect of the pulse can be best appreciated after the activation of the promoter in individual cells. Thus, we set the time of promoter activation for each particular cell as its time zero. The hypothesis of the two distributions being different can be rejected (p = 0.46). For comparing the effect of a late pulse preceded or not by an early pulse (i.e., double or late, second and third row in Figure 5A ), we had to follow a slightly different procedure. The time of promoter activation of the late pulse in the double experiment could not be identified, since the Venus signal from the early pulse was still evident. We thus compared the traces from the beginning of the pulse. Again, the Kolmogorov-Smirnov test rejected the hypothesis that the two distributions were different (p = 0.07). This less robust value-still statistically significant-can be attributed to the fact that here we are not comparing cells from the time of promoter activation, but rather from the beginning of the pulse.
Fluorescence correlation spectroscopy
Yeast growth and sampling Cells were grown at 23C in synthetic complete medium, prepared using yeast nitrogen base lacking folic acid and riboflavin to reduce autofluorescence, and 1% Bacto Peptone, to maximize nocodazole effect in synthetic medium [22] . Cells were sampled and briefly sonicated, then loaded in glass-bottomed well chambers. To immobilize cells, the chambers were pre-treated for at least 30 min with 0.1% Bioconext in EtOH, followed by one ethanol and one water wash steps and incubated overnight at 4 with 1% ConcanavalinA, followed again by two wash steps with water. Approximately 15 min after loading, medium and floating cells were carefully removed from wells and 150 mL of new medium was added.
G1-phase cells were measured after growing 120 to 180 min in a-factor containing medium. Metaphase cells were measured 150 to 210 min after release into nocodazole from G1.
Acquisition settings
The experiments were performed in a room with controlled temperature ($19 C ), using a MicroTime 200 (PicoQuant, Berlin, Germany) time-resolved confocal microscope, controlled using both SymphoTime64 software (PicoQuant) and a custom written Java program (using libraries from ImageJ [28] and mManager [31] ). Cells were excited using a 485nm pulsed laser diode head (LDH-D-C-485, PicoQuant), pulsing at 20MHz and a 561nm CW laser (Cobolt Jive, Cobolt). Power for both lasers was set such that count rates for both fluorophores were below 1% of pulse rate (20MHz) to avoid detector dead-time artifacts [42] and reduce photobleaching. Objective ring-collar was optimized at the beginning of each day to maximize the signal. The laser beam was positioned in the nucleus, identified by the signal from Mad2-GFP. Brightfield images were used to check the correct phase of the cell cycle of the acquired cells. Only one measurement per cell was performed, lasting 45 s. For more details on the microscope settings, see [43] .
Acquisition volumes were determined using calibration dyes Atto-488 and Atto-565 and fitting their autocorrelation functions using SymphoTime64 software (diffusion coefficient = 420 mm 2 /s for both dyes). To compute the overlapping volume we used doublelabeled probes (In vitro FCCS standards 488-543 nm): the overlapping volume was computed such that the concentration of the probe was the same when measured with either channel and with the cross-correlation signal.
Data analysis
For general remarks on FCS/FCCS protocol see [44] , or [45] for a more theoretical approach.
Auto-and cross-correlation functions were computed and fitted using FluctoAnalyzer [30] (see Figure S5A ), correcting for background autofluorescence and green-to-red bleedthrough). The correction values were computed using control strains as in [44] . The background control strain has the same genetic background as target strains, and carries no fluorescent proteins. Bleedthrough control strain carries Don1 tagged with the same GFPs used in the target strains.
The resulting functions were fitted to a two-components model, assuming triplet-like blinking state (see following equation).
The optical parameter k is fitted using the calibration dyes. From this function we can compute G(0), which is equal to 1/N, where N is the average number of fluorescent molecules in the confocal volume. We will refer to this value as G rr when studying the red autocorrelation function or G gg when we study the green. From this value we can thus compute the absolute concentration of the two fluorescent proteins, by using the following equation:
where N A is the Avogadro constant and V i is the acquisition volume for the green or red channel. To compute the concentration of the complex we used the following equation (see Ref [45] , page 367):
where the subscript rg represents parameters coming from the fitting of the cross-correlation function. V rg is the overlapping volume, computed as explained previously.
The database containing the fitted parameters was analyzed using an automatized pipeline written using RStudio [32] . We identified as unreliable (e.g: trembling cells, laser beam too close to the outer membrane) and removed all measurements with R 2 < 0.99 for one of the two proteins ($5% of the measurements). Similarly, measurements with R 2 < 0.3 for the cross-correlation fitting were removed (< 0.1%). The reason why we used a lower quality threshold for the complex is to avoid removing cells where the two proteins are not interacting.
The concentration of the complex was expressed in each cell as fold increase with respect to the central value of the complex measured in the CDC20 (1X) strain the same day. This is to take into account day-by-day variability. The central value we used, since the concentrations are distributed mainly lognormally, is e < logðXÞ > where log is the natural logarithm, X the observed data and brackets indicate the average. Kolmogorov-Smirnov test was the choice for pairwise comparisons, either two-tails or one-tail. The following symbols are used: ns p > 0.05, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Explicit p values are written in figure legends.
Mathematical model
We derived the wiring diagram shown in Figure 2B based on experimental evidence [2, 3, [5] [6] [7] [8] 16 ] (see Main Text -Results). We converted it into a SBML model of biochemical reactions that could be used for simulations in Python (Data S1). Deterministic simulations were carried out using the Python package 'SloppyCell' [46, 47] . Stochastic simulations were performed with the Python package 'StochPy' using Gillespie's direct method [48] . Overall the model involves 12 reactions based on mass action kinetics that are listed in Table S2 . Equations The deterministic version of the model consists of a set of ordinary differential equations involving six variables A (APC/C), C (Cdc20), M (Mad2, Mad3,.), AC (APC/C Cdc20 ), MC (MCC), and ACMC (APC/C inhib ). The model is defined by four equations (reaction names are explained in Table S2 ). 
Since the total amounts of APC/C and Mad2, Mad3,. are assumed to be constant, the remaining variables can be determined using the algebraic relations
Parameters Parameters for the model are largely based on experimental results. In line with our FCS measurements ( Figure 2D ), we assume 80nM for M total and 40nM for A total . The latter value is obtained from Cdc23 concentration divided by two, taking into account the stioichiometry of Cdc23 in APC/C [2] . These concentrations translate into 200 molecules of M total and 100 molecules of A total in the stochastic simulations. The conversion factor of 2:5 molecules=nM was calculated using a nuclear volume of z4:2mm 3 , corresponding to a nuclear radius of z1mm [49] . The rates of synthesis and degradation of Cdc20 under wild-type conditions were based on the evidence that Cdc20 is roughly equally expressed as Cdc23 ( Figure 2E ), whose concentration was measured by FCS to be z70nM ( Figure 2D ). Cdc20 half-life was set to z7 min, ( Figures 2C and S2C and [7, 16] ), and synthesis was chosen accordingly to keep the system at steady state during an arrest. For the same reason, we introduced a small background degradation rate acting on all molecular species that include Cdc20.
The choice of MCC dissociation constant ðKD MC hk dissMC =k assMC Þ and APC/C inhib (here ACMC) dissociation constant ðKD ACMC hk dissACMC =k assACMC Þ is also based on experimental data. MCC dissociation constant is in the order of nM according to [50] . We estimated KD ACMC indirectly, as follows. IC 50 for MCC on APC/C Cdc20 was measured to be 4nM [16] . In first approximation, this result implies active APC/C to reach half-maximal levels at 4nM of inhibitor and suggests a value of KD ACMC for the binding of MCC to APC/C Cdc20 around this order of magnitude. Albeit indirectly, these data indicate that KD MC and KD ACMC are in the same order of magnitude. We used for both of them 10 nM.
We found no evidences for KD AC ; however, it is reasonable to suppose it is not lower than KD ACMC . We used 10 nM for this dissociation constant too. We confirmed by numerical simulations that reducing by half or doubling the value of the dissociation constants, either together or independently, does not qualitatively alter the steady-state behavior ( Figure S2B ). For association constants, which have not been measured as far as we are aware, we used reasonable numbers. Association of APC/C to MCC or Cdc20 is in the same order of the association constants of the E2 Ubch10 with APC/C [51] . For MCC formation, we took values comparable with the ratelimiting step, that is Mad2-dimerization [52] . The APC/C-independent background degradation was chosen to be 5 times smaller than the APC/C-dependent degradation.
All parameters are summarized in Table S3 . Alternative wiring 1: ''to APC/C Cdc20 '' In our original model, we assumed that dissociation of inhibited APC/C (ACMC) results in one copy of each of the basic components M, A, and C. Alternatively, one might consider that degradation results in one copy of M and one copy of the active complex AC ( Figure S2A ). Simulations show that the behavior is qualitatively similar to the model shown in Figure 2B (compare solid and dotted lines in the bifurcation diagram of Figure S2B ). Alternative wiring 2: ''with Mad3'' Here, we discuss a version of the model that explicitly incorporates Mad2 and Mad3 as separate species. Mad2 first binds to Cdc20 and in turn to Mad3, thereby forming the MCC. Our FCCS data indicate that the concentration of Mad2 is significantly higher than that of Mad3 ( Figure 2D ). For the simulations we choose Mad2 = 200nM and Mad3 = 80 nM. The wiring diagram and the simulation results are shown in Figures S2A and S2B . Also in this case the behavior is similar to the model in Figure 2B , in particular regarding the saturation for high Cdc20 synthesis rate (ksyn). It seems, however, that introducing Mad2 explicitly results in a buffering effect for smaller values of ksyn. In this condition, a large fraction of C is bound in intermediary complexes (Mad2:Cdc20, MCC) and less of it is available for the formation of AC and ACMC. One versus two subpopulations Our stochastic model of adaptation is based on the idea that all cells have the same adaptation rate at any point in time. This hypothesis is in excellent agreement with the observed distribution of adaptation times. However, it is not obvious that based on this we can exclude the existence of subpopulations of cells with different probabilities. We therefore compared the simple exponential model (one adaptation rate q describing the whole population) with a mixture model of two exponential distributions (two adaptation rates q 1 and q 2 plus one parameter fixing the relative sizes of the subpopulations). We measured model performance (i.e., goodness of fit) by estimating maximum likelihood using the R package 'Renext' (https://CRAN.R-project.org/package=Renext).
First, we compared the performance of the simple model for the experimentally measured adaptation time data and for artificially generated data drawn from a simple exponential distribution. We found that the performance is very similar (log-likelihood = À 1522 for the experimental and À1515 ± 30 for the artificial data), thus confirming that our experimental data are in excellent agreement with the simple model.
Then, we generated artificial datasets drawn from a mixed exponential distribution with increasingly different ratios for q 1 and q 2 (blue dots in Figure S2F ). Outside a small region around q 1 =q 2 = 1 the mixed model always clearly outperforms the simple model. On the experimental dataset, the fitting of the mixed model gives q 1 = q 2 and thus identical likelihood for mixed and simple model (dashed red line in Figure S2F ). This result provides evidence against the existence of subpopulations with different adaptation probabilities.
